A qualitative study of perspectives on access to tuberculosis health services in Xigaze, China.
Access
China
Qualitative research
Quality of care
Rural health
Tuberculosis
Journal
Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645
Informations de publication
Date de publication:
20 Sep 2021
20 Sep 2021
Historique:
received:
19
07
2021
accepted:
08
09
2021
entrez:
21
9
2021
pubmed:
22
9
2021
medline:
28
9
2021
Statut:
epublish
Résumé
Tuberculosis (TB) is a major global health threat and the leading infectious disease cause of death worldwide. Access to and retention in TB care remains a challenge for patients, particularly those living in rural and remote settings. This qualitative study explored barriers and facilitators to accessing and maintaining contact with TB care services in communities in Xigaze (Shigatse) prefecture, Xizang Autonomous Region (Tibet Autonomous Region), China from the perspective of persons impacted by TB. We conduced in-depth interviews with 23 participants impacted by TB in four rural districts in Xigaze prefecture, Xizang Autonomous Region, China between April 2019 and November 2020. Interviews were conducted in Tibetan and Mandarin, transcribed in Mandarin and translated into English. Transcripts were checked against recordings by native Tibetan and Mandarin speakers. QSR NVivo12 software was used for framework analysis guided by an access to care conceptual framework by Levesque et al. RESULTS: Overall patients reported low awareness of and an indifferent attitude towards TB, although all reported understanding the need to adhere to treatment. Participants reported complex pathways to care, often requiring visits to multiple healthcare facilities. Some participants reported visiting traditional Tibetan medicine (TTM) providers. Participants reported various barriers to accessing care including challenges physically reaching care, out-of-pocket payments for tests, diagnostics and transport. Barriers to maintaining care included medication side effects and worry about treatment effectiveness. Enablers to accessing care identified included knowledge or past experience with TB, integrated models of TTM and western care, supportive village doctors who conducted home visits, free TB treatment and other subsidies, as well as having family support with care and social support as barriers and facilitators to maintaining treatment. We identified barriers and facilitators to accessing services in rural communities in Xigaze from the perspective of persons impacted by TB. Challenges include complex pathways to care, travel distances, wait times and low awareness. Tuberculosis care in the region could be strengthened by ongoing culturally tailored educational campaigns to increase awareness, partnerships with TTM providers, providing comprehensive treatment subsidies and strengthening the role of family members in comprehensive TB care.
Sections du résumé
BACKGROUND
BACKGROUND
Tuberculosis (TB) is a major global health threat and the leading infectious disease cause of death worldwide. Access to and retention in TB care remains a challenge for patients, particularly those living in rural and remote settings. This qualitative study explored barriers and facilitators to accessing and maintaining contact with TB care services in communities in Xigaze (Shigatse) prefecture, Xizang Autonomous Region (Tibet Autonomous Region), China from the perspective of persons impacted by TB.
METHODS
METHODS
We conduced in-depth interviews with 23 participants impacted by TB in four rural districts in Xigaze prefecture, Xizang Autonomous Region, China between April 2019 and November 2020. Interviews were conducted in Tibetan and Mandarin, transcribed in Mandarin and translated into English. Transcripts were checked against recordings by native Tibetan and Mandarin speakers. QSR NVivo12 software was used for framework analysis guided by an access to care conceptual framework by Levesque et al. RESULTS: Overall patients reported low awareness of and an indifferent attitude towards TB, although all reported understanding the need to adhere to treatment. Participants reported complex pathways to care, often requiring visits to multiple healthcare facilities. Some participants reported visiting traditional Tibetan medicine (TTM) providers. Participants reported various barriers to accessing care including challenges physically reaching care, out-of-pocket payments for tests, diagnostics and transport. Barriers to maintaining care included medication side effects and worry about treatment effectiveness. Enablers to accessing care identified included knowledge or past experience with TB, integrated models of TTM and western care, supportive village doctors who conducted home visits, free TB treatment and other subsidies, as well as having family support with care and social support as barriers and facilitators to maintaining treatment.
CONCLUSIONS
CONCLUSIONS
We identified barriers and facilitators to accessing services in rural communities in Xigaze from the perspective of persons impacted by TB. Challenges include complex pathways to care, travel distances, wait times and low awareness. Tuberculosis care in the region could be strengthened by ongoing culturally tailored educational campaigns to increase awareness, partnerships with TTM providers, providing comprehensive treatment subsidies and strengthening the role of family members in comprehensive TB care.
Identifiants
pubmed: 34544492
doi: 10.1186/s40249-021-00906-4
pii: 10.1186/s40249-021-00906-4
pmc: PMC8451167
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
120Subventions
Organisme : tb reach
ID : STBP/TBREACH/GSA/W6-5
Informations de copyright
© 2021. The Author(s).
Références
Int J Tuberc Lung Dis. 2015 Apr;19(4):413-9
pubmed: 25859996
Public Health Rep. 1992 Nov-Dec;107(6):626-36
pubmed: 1454974
Infect Dis Poverty. 2018 Jan 12;7(1):3
pubmed: 29325589
Eur Respir J. 2014 Jun;43(6):1763-75
pubmed: 24525439
Int J Equity Health. 2015 May 14;14:45
pubmed: 25971748
Int J Tuberc Lung Dis. 2016 Nov;20(11):1495-1500
pubmed: 27776591
BMC Health Serv Res. 2008 Oct 02;8:202
pubmed: 18828929
Int J Equity Health. 2016 Jul 07;15(1):100
pubmed: 27388710
BMC Public Health. 2008 Nov 26;8:393
pubmed: 19036164
PLoS One. 2017 Aug 1;12(8):e0181205
pubmed: 28763456
PLoS One. 2015 May 20;10(5):e0126770
pubmed: 25993411
Can Commun Dis Rep. 2017 Mar 02;43(3-4):77-82
pubmed: 29770069
BMC Med. 2013 Jul 02;11:156
pubmed: 23819847
BMC Infect Dis. 2020 Aug 24;20(1):623
pubmed: 32831050
Bull World Health Organ. 2014 Feb 1;92(2):126-38
pubmed: 24623906
Infect Dis Poverty. 2016 Jan 28;5:8
pubmed: 26818723
Int J Tuberc Lung Dis. 2018 Sep 1;22(9):983-990
pubmed: 30092862
Int J Evid Based Healthc. 2014 Mar;12(1):3-16
pubmed: 24685895
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):735-740
pubmed: 31315707
Int Q Community Health Educ. 2010;31(2):187-202
pubmed: 21840815
Glob Health Action. 2018;11(1):1477493
pubmed: 29902134
BMC Infect Dis. 2019 May 29;19(1):481
pubmed: 31142288
Trop Med Int Health. 2011 Apr;16(4):394-411
pubmed: 21320240
PLoS Med. 2007 Jul 24;4(7):e238
pubmed: 17676945
Trials. 2019 May 16;20(1):273
pubmed: 31097023
BMC Public Health. 2017 Feb 22;17(1):221
pubmed: 28222724
BMC Health Serv Res. 2009 Sep 18;9:169
pubmed: 19765290
Int J Tuberc Lung Dis. 2000 May;4(5):401-8
pubmed: 10815732
Patient Prefer Adherence. 2020 Jul 10;14:1149-1158
pubmed: 32764888
BMC Pulm Med. 2017 Dec 13;17(1):202
pubmed: 29237451
PLoS One. 2021 May 20;16(5):e0250971
pubmed: 34014938
World Health Popul. 2011;12(4):5-13
pubmed: 21677530
Int J Tuberc Lung Dis. 2000 Feb;4(2):133-8
pubmed: 10694091
Trans R Soc Trop Med Hyg. 2005 May;99(5):355-62
pubmed: 15780342
East Mediterr Health J. 2020 Apr 16;26(4):477-486
pubmed: 32338367
J Clin Tuberc Other Mycobact Dis. 2020 Jan 11;19:100144
pubmed: 32072022
Am J Trop Med Hyg. 2010 Oct;83(4):902-5
pubmed: 20889888
Int J Tuberc Lung Dis. 2004 Jan;8(1):70-5
pubmed: 14974748
PLoS One. 2013 Nov 25;8(11):e82503
pubmed: 24282623
BMC Public Health. 2020 Sep 16;20(1):1409
pubmed: 32938411
Nurs Outlook. 2005 May-Jun;53(3):127-33
pubmed: 15988449
Trop Med Int Health. 2015 Mar;20(3):304-11
pubmed: 25430477
Health Policy. 2007 Jul;82(2):186-99
pubmed: 17055105
Lancet. 2014 Jun 14;383(9934):2057-2064
pubmed: 24650955
BMC Infect Dis. 2013 Feb 20;13:93
pubmed: 23425261
Indian J Tuberc. 2019 Oct;66(4):448-460
pubmed: 31813431
BMJ Open. 2014 Jun 10;4(6):e004818
pubmed: 24916087
BMC Infect Dis. 2018 Dec 20;18(1):690
pubmed: 30572830
BMC Health Serv Res. 2013 Jan 17;13:25
pubmed: 23327613
EPMA J. 2011 Dec;2(4):385-9
pubmed: 23194325
Int J Equity Health. 2013 Mar 11;12:18
pubmed: 23496984
BMJ Glob Health. 2018 Oct 11;3(5):e001018
pubmed: 30364330
Trop Med Int Health. 2018 Jun;23(6):668-677
pubmed: 29691959
Trans R Soc Trop Med Hyg. 2016 Mar;110(3):192-8
pubmed: 26884500
Ann Trop Med Parasitol. 2005 Dec;99(8):781-7
pubmed: 16297291
BMC Public Health. 2019 Jun 10;19(1):721
pubmed: 31182067
Health Policy. 2004 Jan;67(1):93-106
pubmed: 14726009
Trop Med Int Health. 2009 Jul;14(7):754-60
pubmed: 19392747